Fig. 1From: Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio®) for the prevention of Thelazia callipaeda canine eyeworm infectionMap of the study area. Black dots show the exact geographical location in France and Italy where the study was performedBack to article page